NN-841

N/A

Report date: 2025/03/27 15:50:12

Base Information

Drug NameNN-841
Drug Alias NameNN-841
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes NN-103NN-224
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoNewron LLC
China Registration ClassN/A

Develop Information

Active CompaniesNanoNewron LLC
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A